Vanda Pharmaceutical's experimental Covid-19 drug shows promise in interim trial data

Covid-19 patients with pneumonia improved faster when administered with its experimental therapy than those on placebo, Vanda Pharmaceuticals Inc said on Tuesday, citing an interim analysis of data from a late-stage study.

COVID-19 Pandemic Tracker: 15 countries with the highest number of coronavirus cases, deaths

Vanda said the data was from 60 patients enrolled in the trial, which aims to enroll 300 patients eventually.